BlomR.J., KuksJ.B.M., Westerterp-MaasA., OosterhuisHJGH. Favourable results of plasma exchange in severe myasthenia gravis.Ned Tijdschr Geneeskd1997; 141: 381–4.
19.
DauP.C.. Response to plasmapheresis and immunosuppressive drug therapy in sixty myasthenia gravis patients.Ann NY Acad Sci1981; 377: 700–8.
20.
FornadiL., HorvathR., SzoborA.. Myasthenia Gravis: Treatment with plasma exchange. Experiences over 10 years.Acta Med Hung1991; 48: 137–44.
21.
SatoT., NishimiyaJ., AraiK.. Selective removal of anti-acetylcholine receptor antibodies in sera from patients with myasthenia gravis in vitro with a new immunosorbent. In: OdaT. ed. Therapeutic Plasmapheresis. Vol III. Stuttgart: SchattauerVerlag. 1983; 565–8.
22.
SzpirtW., SomnierF., GammeltoftS.. Removal of anti acetylcholine receptor antibodies by immunoadsorption to protein A column.Artif Organs1985; 10: 71–82.
23.
GrobD., SimpsonD., MitsumotoH.. Treatment of myasthenia gravis by immunoadsorption of plasma.Neurol1995; 45: 338–44.
GajdosPh, OutinH.D., ElkharratD.. High dose interve-nous gamma globulin for myasthenia gravis.Lancet1984; i: 406–7.
26.
EdanG., LandgrafF.. Experience with intravenous immunoglobulin in myasthenia gravis: a review.J Neurol Neurosurg Psychiat1994; 57: 55–6.
27.
GelfandE.W.. Intervention in autoimmune disorders: creation of a niche for intravenous gamma-globulin therapy.Clin Immunol Immunopathol1989; 53(suppl): S1–6.
28.
GajdosPh, ChevretS., ClairB., TranchantC., ChastangC.. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis.Ann Neurol1997; 41: 789–96.
29.
DalakasM.C.. High-dose intravenous immunoglobulin and serum visocosity: risk of precipitating thromboembolic events.Neurology1994; 44: 223–6.
30.
StriekerR.B., KwiatkowskaB.J., HabisJ.A., KiprovD.D.. Myasthenic crisis. Response to plasmapheresis following failure of intravenous gamma-globulin.Arch Neurol1993; 50: 837–40.
31.
BusselJ.B., SaalS., GordonB.. Combined plasma exchange and intravenous gammaglobulin in the treatment of patients with refractory immune thrombocytopenic purpura.Transfusion1988; 28: 38–41.
